{"id":"https://openalex.org/W2581626307","doi":"https://doi.org/10.15406/htij.2017.04.00071","title":"Retrospective Analysis of Epsilon-Amino-Caproic Acid (EACA) Therapy in Patients with Hypoproliferative Thrombocytopenia","display_name":"Retrospective Analysis of Epsilon-Amino-Caproic Acid (EACA) Therapy in Patients with Hypoproliferative Thrombocytopenia","publication_year":2017,"publication_date":"2017-01-26","ids":{"openalex":"https://openalex.org/W2581626307","doi":"https://doi.org/10.15406/htij.2017.04.00071","mag":"2581626307"},"language":"en","primary_location":{"id":"doi:10.15406/htij.2017.04.00071","doi":"https://doi.org/10.15406/htij.2017.04.00071","is_oa":true,"landing_page_url":"https://doi.org/10.15406/htij.2017.04.00071","pdf_url":"https://medcraveonline.com/HTIJ/HTIJ-04-00071.pdf","source":{"id":"https://openalex.org/S2765025308","display_name":"Hematology & Transfusion International Journal","issn_l":"2469-2778","issn":["2469-2778"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology &amp; Transfusion International Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://medcraveonline.com/HTIJ/HTIJ-04-00071.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068792990","display_name":"Terry Gernsheimer","orcid":"https://orcid.org/0000-0002-2671-5608","observed_orcids":["https://orcid.org/0000-0002-2671-5608","https://orcid.org/0000-0003-3631-8654"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Terry Gernsheimer","raw_affiliation_strings":["Division of Hematology, University of Washington, 1959 NE Pacific Street, Box 356330, Seattle, WA, 98195, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Washington, 1959 NE Pacific Street, Box 356330, Seattle, WA, 98195, USA,","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068792990"],"corresponding_institution_ids":["https://openalex.org/I201448701"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00596325,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"4","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.21250000596046448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epsilon-aminocaproic-acid","display_name":"epsilon-aminocaproic acid","score":0.7689999938011169},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.7239999771118164},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8999999761581421},{"id":"https://openalex.org/keywords/platelet-refractoriness","display_name":"platelet transfusion refractoriness","score":0.9279999732971191},{"id":"https://openalex.org/keywords/blood-product-requirements","display_name":"blood product requirements","score":0.5759999752044678},{"id":"https://openalex.org/keywords/hemostasis","display_name":"hemostasis","score":0.4970000088214874},{"id":"https://openalex.org/keywords/intracerebral-hemorrhage","display_name":"intracerebral hemorrhage","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2908570505","wikidata":"https://www.wikidata.org/wiki/Q422597","display_name":"Caproic Acid","level":2,"score":0.7393239140510559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7082552909851074},{"id":"https://openalex.org/C2778153459","wikidata":"https://www.wikidata.org/wiki/Q953638","display_name":"Wiskott\u2013Aldrich syndrome","level":3,"score":0.6459334492683411},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.5715391635894775},{"id":"https://openalex.org/C2776952295","wikidata":"https://www.wikidata.org/wiki/Q541244","display_name":"Hereditary spherocytosis","level":2,"score":0.4580170214176178},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.44122999906539917},{"id":"https://openalex.org/C2993683473","wikidata":"https://www.wikidata.org/wiki/Q30693176","display_name":"Amino acid substitution","level":4,"score":0.41193193197250366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36393558979034424},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.20361068844795227},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11165976524353027},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.09653854370117188},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08365070819854736},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.15406/htij.2017.04.00071","doi":"https://doi.org/10.15406/htij.2017.04.00071","is_oa":true,"landing_page_url":"https://doi.org/10.15406/htij.2017.04.00071","pdf_url":"https://medcraveonline.com/HTIJ/HTIJ-04-00071.pdf","source":{"id":"https://openalex.org/S2765025308","display_name":"Hematology & Transfusion International Journal","issn_l":"2469-2778","issn":["2469-2778"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology &amp; Transfusion International Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.15406/htij.2017.04.00071","doi":"https://doi.org/10.15406/htij.2017.04.00071","is_oa":true,"landing_page_url":"https://doi.org/10.15406/htij.2017.04.00071","pdf_url":"https://medcraveonline.com/HTIJ/HTIJ-04-00071.pdf","source":{"id":"https://openalex.org/S2765025308","display_name":"Hematology & Transfusion International Journal","issn_l":"2469-2778","issn":["2469-2778"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320093","host_organization_name":"MedCrave Group","host_organization_lineage":["https://openalex.org/P4310320093"],"host_organization_lineage_names":["MedCrave Group"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology &amp; Transfusion International Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2581626307.pdf","grobid_xml":"https://content.openalex.org/works/W2581626307.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1506035634","https://openalex.org/W1582845209","https://openalex.org/W1973797866","https://openalex.org/W2061293556","https://openalex.org/W2070586531","https://openalex.org/W2074120475","https://openalex.org/W2085071162","https://openalex.org/W2093255106","https://openalex.org/W2103029594","https://openalex.org/W2163299160","https://openalex.org/W2165510376","https://openalex.org/W2166126320","https://openalex.org/W2167805334","https://openalex.org/W2169344158","https://openalex.org/W2312239978","https://openalex.org/W2466553623","https://openalex.org/W4247907436"],"related_works":["https://openalex.org/W1582845209","https://openalex.org/W1973797866","https://openalex.org/W2595430543","https://openalex.org/W2246668084","https://openalex.org/W2165510376","https://openalex.org/W2995620040","https://openalex.org/W2085071162","https://openalex.org/W2034704200","https://openalex.org/W2408362046","https://openalex.org/W2003061155"],"abstract_inverted_index":{"Bleeding":[0],"still":[1],"contributes":[2],"to":[3,55,59,127,163,180],"significant":[4],"morbidity":[5],"and":[6,56,73,85,105,113,134,146,154,159],"mortality":[7],"in":[8,33,79,83,87,89,106,185],"patients":[9,44,68,92,119],"with":[10,14,45,74,93,108],"hypoproliferative":[11],"thrombocytopenia":[12],"even":[13],"optimal":[15],"platelet":[16,128,145],"transfusion":[17],"support.We":[18],"hypothesized":[19],"that":[20,172],"Epsilon-amino-caproic":[21],"acid":[22],"(EACA)":[23],"therapy":[24,174],"might":[25],"stabilize":[26],"a":[27,177],"hemostatic":[28],"plug":[29],"thereby":[30],"reducing":[31],"bleeding":[32,72,77,95,103,133,184],"these":[34,67],"patients.Over":[35],"six":[36],"years":[37],"at":[38],"our":[39],"hospital,":[40],"data":[41,170],"from":[42],"133":[43],"hematologic":[46],"malignancies":[47],"were":[48],"retrospectively":[49],"analyzed":[50],"for":[51,57],"three":[52],"days":[53,61],"prior":[54],"up":[58],"seven":[60],"after":[62],"starting":[63],"EACA":[64,75,168,173],"therapy.Ninety-nine":[65],"of":[66,125],"(74%)":[69],"had":[70,131,136],"active":[71],"therapy,":[76],"decreased":[78,150],"66%,":[80],"was":[81],"unchanged":[82],"26%":[84],"increased":[86],"8%.Even":[88],"the":[90,116],"45":[91],"severe":[94],"(WHO":[96],"Grades":[97],"3":[98,111,114],"or":[99,182],"4),":[100],"62%":[101],"showed":[102],"improvement":[104],"6":[107],"intra-cerebral":[109],"bleeding,":[110],"improved":[112],"stabilized.In":[115],"remaining":[117],"34":[118],"treated":[120,143],"prophylactically":[121],"(26%),":[122],"usually":[123],"because":[124],"refractoriness":[126],"transfusions,":[129],"91%":[130],"no":[132],"9%":[135],"only":[137],"WHO":[138],"Grade":[139],"1":[140],"bleeding.Among":[141],"all":[142],"patients,":[144],"red":[147],"cell":[148],"transfusions":[149],"significantly":[151],"by":[152],"0.25":[153],"0.24":[155],"units":[156],"transfused/patient/day":[157],"(p<0.003":[158],"p<0.001":[160],"respectively)":[161],"compared":[162],"blood":[164],"product":[165],"requirements":[166],"before":[167],"therapy.These":[169],"suggest":[171],"may":[175],"be":[176],"useful":[178],"adjuvant":[179],"treat":[181],"prevent":[183],"thrombocytopenic":[186],"patients.":[187]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-03T00:00:00"}